Literature DB >> 12180556

A discussion of the concept of technology transfer of research-based drug "abuse" prevention and treatment interventions.

Zili Sloboda1, Sam Schildhaus.   

Abstract

With the availability of both drug user prevention and treatment interventions that have demonstrated effectiveness under rigorous experimental design, new avenues of research have opened up to bring these strategies to scale. Of major importance is adapting evidence-based prevention and treatment programs to community specifications without diluting their power. A number of researchers have examined this issue from a variety of perspectives. This brief discussion is an attempt to bring those perspectives together within a conceptual framework that integrates them around research issues and questions. Several theoretical perspectives that have not been brought into the technology transfer discussion are mentioned, others need to be reviewed for their potential to guide further research in this area.

Mesh:

Substances:

Year:  2002        PMID: 12180556     DOI: 10.1081/ja-120004167

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  8 in total

1.  Timing of buprenorphine adoption by privately funded substance abuse treatment programs: the role of institutional and resource-based interorganizational linkages.

Authors:  Sarah A Savage; Amanda J Abraham; Hannah K Knudsen; Tanja C Rothrauff; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2011-08-09

2.  Strategies to encourage adoption in multisite clinical trials.

Authors:  Joseph Guydish; Barbara Tajima; Sarah Turcotte Manser; Martha Jessup
Journal:  J Subst Abuse Treat       Date:  2006-11-22

3.  Adopting best practices: lessons learned in the Collaborative Initiative to Help End Chronic Homelessness (CICH).

Authors:  Sarah A McGraw; Mary Jo Larson; Susan E Foster; Marilyn Kresky-Wolff; Elizabeth M Botelho; Emily A Elstad; Ana Stefancic; Sam Tsemberis
Journal:  J Behav Health Serv Res       Date:  2009-07-31       Impact factor: 1.505

4.  Program Capacity to Eliminate Outcome Disparities in Addiction Health Services.

Authors:  Erick G Guerrero; Gregory A Aarons; Christine E Grella; Bryan R Garner; Benjamin Cook; William A Vega
Journal:  Adm Policy Ment Health       Date:  2016-01

5.  Facilitating factors and barriers to the use of medications in publicly funded addiction treatment organizations.

Authors:  Hannah K Knudsen; Paul M Roman; Carrie B Oser
Journal:  J Addict Med       Date:  2010-06       Impact factor: 3.702

6.  Differences in Substance Abuse Counselors' Knowledge of Tobacco Cessation Medication Effectiveness: 2002-2008.

Authors:  Tanja C Rothrauff; Amanda J Abraham; Paul M Roman
Journal:  J Drug Issues       Date:  2011-01

7.  The relative efficacy of pamphlets, CD-ROM, and the Internet for disseminating adolescent drug abuse prevention programs: an exploratory study.

Authors:  Jennifer Di Noia; Traci M Schwinn; Zubin A Dastur; Steven P Schinke
Journal:  Prev Med       Date:  2003-12       Impact factor: 4.018

8.  State policy influence on the early diffusion of buprenorphine in community treatment programs.

Authors:  Lori J Ducharme; Amanda J Abraham
Journal:  Subst Abuse Treat Prev Policy       Date:  2008-06-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.